My ePortfolio Register   

Targeted therapy for brain and CNS tumours

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.07.17
Views: 718

Dr Mary Jo Fidler - Rush University Medical Center, Chicago, USA

Dr Fidler speaks with ecancer at NOSCM 2017 about treating brain and central nervous system cancers with EGFR and ALK mutations.

She describes how results from small phase I trials are providing useful insights into rare or relapsed diseases, and outlines promising agents, including alectinib in place of crizotinib

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence